Implementation of Guideline-Based Screening for a Genetic and Treatable Cause of COPD: Session 3 - January 31, 2023 Virtual Grand Rounds
Thank you for attending Implementation of Guideline-Based Screening for a Genetic and Treatable Cause of COPD on January 31, 2023. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to claim your credit on the following page.
This activity is intended for primary care clinicians, including physicians, nurse practitioners, physician assistants, and nurses.
Upon completion, participants should be able to:
- Recognize the importance of screening patients with COPD or emphysema for AATD.
- Summarize recommendations to support areas of improvement and address persistent barriers to AAT screening at their medical center.
This activity is funded by an independent medical education grant from Takeda.
Steering Committee Disclosures
Andrew Wilson, MD, CME Course Director receives research support from Beam Therapeutics and Grifols.
Catherine Silva, MD; Celia Bora, DNP, NCPD Nurse Advisor; and Cammie Townsend, NP, MS/MBA, RN Accredited Provider Program Director have no relevant financial relationships to disclose
Jaime Symowicz, PhD, Planning Committee; Natalie Sanfratello, MPH, Planning Committee; Larissa Picard-Broussard, Planning Committee; Amy Sison, Planning Committee; Julie White, MS, Planning Committee; and Cristen Querey, MS Planning Committee; and Donna Gabriel, MS have no relevant financial relationships to disclose
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Med-IQ. Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this Live Activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Contact Hours: 0.75 of which 0 are eligible for pharmacology credit
- 0.75 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 0.75 ANCC
- 0.00 ANCC Pharmacology
- 0.75 Participation
Please click on "Take Course" above to begin the credit claiming process.
THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.